As of 2024-12-14, the Fair Value of Entheon Biomedical Corp (ENBI.CN) is -0.17 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.17 CAD, the upside of Entheon Biomedical Corp is -202.15%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-03-31 | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 5Y Avg | |
| Net income | -0.15 | -4.38 | -8.89 | -8.52 | -0.30 | -4.45 |
| YoY growth | 6.82% | -2,885.07% | -102.82% | 4.12% | 96.48% | -576.09% |
| Market Cap (mil) | 1.51 |
| P/E | |
| Forward P/E |
| EPS | -0.03 |
| Avg earnings growth rate | -576.09% |
| TTM earnings | -0.31 |